Skip to main content
Median Diagnostics Inc. logo

Median Diagnostics Inc. — Investor Relations & Filings

Ticker · 233250 ISIN · KR7233250000 KO Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2022-03-08 Proxy Solicitation & In…
Country KR South Korea
Listing KO 233250

About Median Diagnostics Inc.

https://www.mediandiagnostics.com/en

Median Diagnostics Inc. specializes in the development, manufacturing, and supply of in-vitro diagnostic products for animal diseases. The company provides a comprehensive portfolio of diagnostic solutions, including ELISA and PCR kits, rapid tests, and standard reagents. It also produces essential raw materials such as monoclonal antibodies and antigens. A primary focus is on offering 'Total Diagnostic Systems' for high-consequence animal diseases, including African Swine Fever (ASF), Foot-and-Mouth Disease (FMD), High Pathogenicity Avian Influenza (HPAI), Porcine Epidemic Diarrhea (PED), and Bovine Viral Diarrhea (BVD). The company also supplies raw materials for human disease diagnostic applications.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Median Diagnostics. It contains the meeting agenda, including the approval of financial statements, election of directors, and remuneration limits. This type of document is standard for providing shareholders with information and requesting their votes for an upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2022-03-08 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Median Diagnostics. It provides a summary of the audit opinion (unqualified/proper), key financial data (assets, liabilities, revenue, profit), and auditor information. While it contains financial data, it is a standard regulatory disclosure announcing the receipt and submission of the audit report to the exchange, rather than the full annual report or a standalone audit report document itself. Following the 'Menu vs Meal' rule, this is a formal notification of the filing of the audit report. FY 2021
2022-03-08 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Median Diagnostics. It outlines the date, location, and agenda items (such as financial statement approval and director appointments) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2022-02-18 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for the purpose of an upcoming Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given it is a standard regulatory notification that does not fit into specific categories like AGM-R or PSI, it is classified as a general regulatory filing.
2021-12-16 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a short, structured announcement detailing the results of an Investor Relations (IR) meeting held by Median Diagnostics. It lists the date, time, location, attendees, and agenda items of the meeting, and provides a link to where the actual IR materials are posted. Since it is a brief notification regarding the occurrence of an event and the availability of materials rather than the full presentation deck itself, it falls under the category of a regulatory announcement regarding report/event publication.
2021-11-03 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location (online), purpose, and agenda for the upcoming event. Since it is an announcement of an event rather than the presentation materials themselves or a full report, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2021-10-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.